CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 15 filers reported holding CLEVELAND BIOLABS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 25 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 25 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 25 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 25 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 25 | -32.4% | 0.00% | – |
Q3 2017 | $0 | – | 37 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 37 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 37 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 37 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 37 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 37 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 320,053 | $1,104,000 | 0.04% |
Renaissance Technologies | 165,651 | $571,000 | 0.00% |
VANGUARD GROUP INC | 52,592 | $181,000 | 0.00% |
UBS Group AG | 4,812 | $17,000 | 0.00% |
IFP Advisors, Inc | 150 | $1,000 | 0.00% |
OSAIC HOLDINGS, INC. | 290 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 100 | $0 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 15,000 | $52,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |